PROTOCOLOS CLÍNICOS E DIRETRIZES TERAPÊUTICAS

Acne Grave Acne Grave Report/Technology Assessment: Number 17 [Internet]. Rockville (MD): AHRQ; [cited 2010 May 5]. Publication No. 01-E018; Mar 2001. Available from: http://www.ahrq.gov/clinic/epcsums/acnesum.htm. 15. Peck GL, Olsen TG, Butkus D, Pandya M, Arnaud-Battandier J, Gross EG, et al. Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study. J Am Acad Dermatol. 1982;6(4 Pt 2 Suppl):735-45. 16. Prendiville JS, Logan RA, Russell-Jones R. A comparison of dapsone with 13-cis retinoic acid in the treatment of nodular cystic acne. Clin Exp Dermatol. 1988;13(2):67-71. 17. Lester RS, Schachter GD, Light MJ. Isotretinoin and tetracycline in the management of severe nodulocystic acne. Int J Dermatol. 1985;24(4):252-7. 18. Farrel LN, Strauss JS, Stranieri AM. The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial. Am Acad Dermatol. 1980;3(6):602-11. 19. King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol. 1982;107(5):583-90. 20. Jones DH, King K, Miller AJ, Cunliffe WJ. A dose-response study of 13-cis-retinoic acid in acne vulgaris. Br J Dermatol. 1983;108(3):333-43. 21. Stewart ME, Benoit AM, Stranieri AM, Rapini RP, Strauss JS, Downing DT. Effect of oral 13-cis- retinoic acid at three dose levels on sustainable rates of sebum secretion and on acne. J Am Acad Dermatol 1983;8(4):532-8. 22. van der Meeren HL, van der Schroeff JG, Stijnen T, van Duren JA, van der Dries HA, van Voorst Vader PC. Dose-response relationship in isotretinoin therapy for conglobate acne. Dermatologica. 1983;167(6):299-303. 23. Strauss JS, Rapini RP, Shalita AR, Konecky E, Pochi PE, Comite H, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol. 1984;10(3):490-6. 24. Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vulgaris – 10 years later: a safe and successful treatment. Br J Dermatol. 1993;129(3):292-6. 25. Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol. 2001;11(6):538-44. 26. Kaymak Y, Ilter N. The results and side effects of systemic isotretinoin treatment in 100 patients with acne vulgaris. Dermatol Nurs. 2006;18(6):576-80. 27. Akman A, Durusoy C, Senturk M, Koc CK, Soyturk D, Alpsoy E. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res. 2007;299(10):467-73. 28. Oprica C, Emtestam L, Hagströmer L, Nord CE. Clinical and microbiological comparisons of isotretinoin vs tetracycline in acne vulgaris. Acta Derm Venereol. 2007;87(3):246-54. 29. Chivot M. Retinoid therapy for acne. A comparative review. Am J Clin Dermatol. 2005;6(1):13-9. 30. Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther.2006;19 (5):272-9. 31. Stainforth JM, Layton AM, Taylor JP, Cunliffe WJ. Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course? Br J Dermatol. 1993;129(3):297-301. 32. Zane LT, Leyden WA, Marqueling BA, Manos MM.A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol. 2006;142(8):1016-22. 33. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol. 2001;45(4):515-9. 34. Ferahbas A, Turan MT, Esel E, Utas S, Kutlugun C, Kilic CG. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin. J Dermatolog Treat. 2004;15(3):153-7. 35. Bremner JD, Fani N, Ashraf A, Votaw JR, Brummer ME, Cummins T, et al. Functional brain imaging alterations in acne patients treated with isotretinoin. Am J Psychiatry. 2005;162(5):983-91. 36. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005;24(2):92-102. 37. Orfanos, CE, Zouboulis CC. Oral retinoics in the treatment of seborrhoea and acne. Dermatology. 1998;196(1):140-7. 38. Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol. 2007;63(2):196-205. 27